Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.18
+0.09 (1.34%)
Jun 24, 2026, 12:00 PM EDT - Market open
ARCT Market Cap
ARCT has a market cap or net worth of $203.94 million as of June 24, 2026. Its market cap has decreased by -36.86% in one year.
Market Cap
203.94M
Enterprise Value
13.85M
1-Year Change
-36.86%
Ranking
Category
Stock Price
$7.18
Market Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $203.94M, an increase of 98.00%. That is a compound annual growth rate of 5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 205.50M | 17.97% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 207.27M |
| Galectin Therapeutics | 205.47M |
| Outlook Therapeutics | 205.47M |
| Immunic | 205.28M |
| Alector | 203.18M |
| Minerva Neurosciences | 202.66M |
| Q32 Bio | 201.44M |
| ProQR Therapeutics | 199.14M |